Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
Clinical and Experimental Dermatology|May 1, 1994
Fibroblastic rheumatismL S Ostlere, H P Stevens, M Jarmulowicz, et al.Clinical and Experimental Dermatology|September 1, 1993
Bullous pemphigoid in infancy--a case report including new immunoblotting observationsL S Ostlere, H Stevens, M M Black, et al.The British Journal of Dermatology|October 1, 1993
Cyclical psoriatic arthritis responding to anti-oestrogen therapyH P Stevens, L S Ostlere, C M Black, et al.International Journal of Dermatology|October 1, 1993
Risk of cancer in relatives of patients with cutaneous melanomaL S Ostlere, R S Houlston, J H Laing, et al.Clinical and Experimental Dermatology|March 1, 1995
Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 yearM P Sheehan, H Stevens, L S Ostlere, et al.The British Journal of Dermatology|September 1, 1985
Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's diseaseM H Rustin, I B Kovacs, S O Sowemimo-Coker, et al.European Journal of Immunology|April 12, 2001
Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone populationL S Taams, J Smith, M H Rustin, et al.The British Journal of Dermatology|February 1, 1990
Pro-inflammatory mediators induce sustained release of prostaglandin E2 from human dermal microvascular endothelial cellsH A Bull, M H Rustin, J Spaull, et al.Clinical Science (London, England : 1979)|March 1, 1986
Increased chemiluminescence of polymorphonuclear leucocytes from patients with progressive systemic sclerosisI B Kovacs, R H Meyrick Thomas, A R Mackay, et al.Clinical Endocrinology|May 14, 1998
Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acneL S Ostlere, G Rumsby, P Holownia, et al.Pageof 8